First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 1,723.20 ($21.04) and last traded at GBX 1,723.20 ($21.04), with a volume of 519 shares traded. The stock had previously closed at GBX 1,702.60 ($20.79).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Price Performance
The company has a current ratio of 9.42, a quick ratio of 9.27 and a debt-to-equity ratio of 0.04. The business has a 50-day moving average of GBX 1,650.47 and a 200 day moving average of GBX 1,590.06. The firm has a market capitalization of £5.09 billion and a PE ratio of -1,566.55.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Recommended Stories
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- How to Use High Beta Stocks to Maximize Your Investing Profits
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- The Role Economic Reports Play in a Successful Investment Strategy
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Conference Calls and Individual Investors
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.